Work

Comparative outcomes of influenza, severe acute respiratory syndrome coronavirus 2, and respiratory syncytial virus community-acquired pneumonia: insights from an Italian retrospective cohort study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Viral pathogens, particularly influenza, respiratory syncytial virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasingly recognized as key contributors to CAP in hospitalized adults. This single-center, retrospective cohort study examined and compared the clinical characteristics and outcomes of adults hospitalized with viral CAP due to influenza, SARS-CoV-2, or respiratory syncytial virus between January 2022 and December 2023 in Milan, Italy. A total of 165 patients with laboratory-confirmed single-virus infection and clinically and radiologically confirmed pneumonia were included. Patients with SARS-CoV-2 pneumonia presented with the highest in-hospital mortality (20.9%) and 12-month all-cause mortality (51.9%). Patients with influenza, although younger, showed increased rates of cardiovascular events and intensive care unit admissions. Bacterial coinfections were most common in influenza cases. Immunocompromised status was the second most frequent comorbidity (37.6%) after arterial hypertension. These findings underscore significant differences in clinical trajectory and long-term outcomes among major viral CAP etiologies and support the need for pathogen-specific management strategies.
Source: IJID Regions
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,380
OpenAlex ID: W7219905237
FWCI:
Cites: 9
Cited by:
Related to: 10